In-line aligned and bottom-up Ag nanorods for surface-enhanced Raman spectroscopy

We have demonstrated surface-enhanced Raman spectroscopy on arrays of Ag nanorods aligned in line by a dynamic oblique deposition technique. For the light polarized along the major axis of the nanorods, the plasma resonance of the Ag nanorods has been tuned to a wavelength suitable for Raman spectroscopy. The average width and the length-to-width ratio of the resulting nanorods are 56 nm and 3.5, respectively, and the nanorods align in line with small gaps of a few 10 nm. The Raman scattering for the polarized light along the nanorods is enhanced significantly as compared with that perpendicular to the nanorods. This polarization dependent Raman enhancement is attributed to the local field concentration at the ends of the nanorods. Since the preparation process is physical and completely bottom up, it is robust in its selection of the materials and is useful in providing the surface-enhanced Raman scattering sensors at low cost. ©2006 American Institute of PhysicsArticl

Ag nanorod arrays tailored for surface-enhanced Raman imaging in the near-infrared region

Using a dynamic oblique angle deposition technique, we demonstrate the direct formation of Ag nanorods with quasi-parallel major axes on a template layer of oxide having a strongly anisotropic surface morphology. The optical properties of the nanorods are tuned by varying the deposition conditions without any pre- or post-treatment, and the resulting Ag nanorod arrays exhibit high surface-enhanced Raman scattering (SERS) activity. In addition to high macroscopic uniformity over a large area, our nanorod arrays contain a high density of isolated nanorods. Using the optimum Ag nanorod arrays, the SERS imaging of the microdroplets of a rhodamine 6G solution is successfully demonstrated. The space resolution of the imaging is of the order of at least a few µm. These features are suitable for the SERS imaging of biomaterials

Novel risk markers for gastric cancer screening: Present status and future prospects

Initial identification of populations at high risk of gastric cancer (GC) is important for endoscopic screening of GC. As serum pepsinogen (PG) test-positive subjects with progression of chronic atrophic gastritis (CAG) show a high likelihood of future cancer development, this population warrants careful follow-up observation as a high-risk GC group. By combining the PG test with Helicobacter pylori (HP) antibody titers, the HP-related chronic gastritis stage can be classified, thus identifying not only a GC high-risk group but also a low-risk group. Among PG test-negative patients without CAG, those with high serum PG II levels and HP antibody titers are thought to have severe gastric mucosal inflammation and the risk of diffuse-type GC is also high. Meanwhile, in gastric mucosae obtained by endoscopic biopsy, HP infection induces aberrant DNA methylation in CpG islands in multiple gene regions and the extent of methylation clearly correlates with GC risk. By quantifying aberrant DNA methylation in suitable gene markers, we can determine the extent of the epigenetic field for cancerization. These novel concepts and risk markers will have many clinical applications in gastrointestinal endoscopy, including more efficient endoscopic GC screening and a strategic approach to metachronous multiple GCs after endoscopic treatment